Talk DIAmond Session track
DMD05 - Environmental Sustainability in Healthcare
Wed, Mar 19, 2025 · 1:00–2:30 PM CET Montreal Room, Congress Center Basel
About this session
This session will explore the intersection of climate change and medicines, featuring opening remarks from the EMA and European Commission. The session will address two key areas: the impact of climate change on medicines and health, and the environmental footprint of medicines development and manufacturing. A new Commission report on research perspectives regarding climate change and health will be introduced, followed by two panel discussions. The first panel will focus on climate change’s effects on medicines access, supply chains, and patient health, while the second will examine sustainable pharmaceutical development, green clinical trials, and industry-wide collaboration to meet environmental goals.
Programme:
- 1. Setting the Scene — Kirsty Reid
- 2. Research Perspectives on the Health Impacts of Climate Change — Tomasz Dyląg
- 3. EMA Actions Towards Environmental Sustainability — Veronika Jekerle
- 4. Panel Discussion: Climate Impact Assessments and Patient Access — Dan Reed, Tomasz Dyląg, Momir Radulović, Tatiana Paul A. De Wée
- 5. Panel Discussion: What is needed and can be done to reach green targets? — Veronika Jekerle, Fiona Adshead, Sarah Ebadi, Dan Reed, Cathie Vielle, matt popkin
Speakers
-
Circular Healthcare Programme Manager · Health Care Without Harm (HCWH) Europe
Panelist
-
Chair of the Sustainable Healthcare Coalition · Sustainable Healthcare Coalition
Panelist
-
Executive Director · Slovenian Medicines and Medical Devices Agency (JAZMP)
Panelist
-
Senior Regulatory Intelligence Director, Cardiovascular Renal and Metabolism · AstraZeneca
Chair
-
Head of Pharmaceutical Quality, Quality and Safety, Human medicines · European Medicines Agency
Chair
